Completes Acquisition of 80% Stake in Sunshine Healthcare, Ghana

Dr Lal PathLabs' Dubai arm (DLPL FZCO, a wholly owned subsidiary) has completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana.

Sat 26 Sep 2026

Acquisition Stake

80% stake in Sunshine Healthcare Limited, Ghana

Subsidiary Structure

SHL becomes a step-down subsidiary of Dr Lal PathLabs

Acquiring Entity

DLPL FZCO, wholly owned Dubai subsidiary

Board Approval Date

July 24, 2026

What was announced

Dr Lal PathLabs has told the exchanges that its wholly owned subsidiary Dr Lal PathLabs FZCO, Dubai has completed the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL), Ghana.

Key points

• The acquisition was carried out in accordance with the agreement and the provisions applicable in Ghana.
• SHL now becomes a step-down subsidiary of Dr Lal PathLabs (a subsidiary of its subsidiary).
• This is a follow-up to the earlier intimation dated July 24, 2026, when the DLPL Dubai board approved the transaction.
• The detailed disclosures required under Regulation 30 were already given in that earlier intimation.

How to read it

This update confirms closure of a transaction that was already announced at the approval stage. It expands the group's diagnostics footprint outside India, in Africa. Because SHL is 80% owned through the Dubai arm, its results are expected to be consolidated into the group as a step-down subsidiary, with a minority interest for the remaining holders.

The communication is signed by the Company Secretary and Compliance Officer.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.